67 related articles for article (PubMed ID: 6876443)
1. [Evaluation of radiation therapy of brain metastases from lung carcinoma using multivariate analysis].
Chatani M; Inoue T; Harada K; Inoue T; Suzuki R
Gan No Rinsho; 1983 Jun; 29(7):771-6. PubMed ID: 6876443
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation for radiotherapy of metastatic brain tumors in lung cancer: prognostic analyses relevant to QOL].
Myojin M; Nishio M; Mizoguchi F; Kawashima K; Mita N; Fujita A
Gan To Kagaku Ryoho; 1998 Jan; 25(1):43-51. PubMed ID: 9464328
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors in patients with brain metastases from lung carcinoma].
Chatani M; Teshima T; Inoue T
Gan No Rinsho; 1989 Oct; 35(13):1596-601. PubMed ID: 2585731
[TBL] [Abstract][Full Text] [Related]
4. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
Chatani M; Matayoshi Y; Masaki N; Inoue T
Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in patients with brain metastases from lung carcinoma.
Chatani M; Teshima T; Hata K; Inoue T
Strahlenther Onkol; 1986 Mar; 162(3):157-61. PubMed ID: 3515602
[TBL] [Abstract][Full Text] [Related]
7. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
8. The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer.
Gülbaş H; Erkal HS; Serin M
Jpn J Clin Oncol; 2006 Apr; 36(4):193-6. PubMed ID: 16611661
[TBL] [Abstract][Full Text] [Related]
9. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.
Kepka L; Cieslak E; Bujko K; Fijuth J; Wierzchowski M
Acta Oncol; 2005; 44(4):389-98. PubMed ID: 16120548
[TBL] [Abstract][Full Text] [Related]
10. [Results of radiotherapy in brain metastasis].
Schultze J; Kaya A; Kimmig B
Rontgenpraxis; 2000; 53(3):102-9. PubMed ID: 11131110
[TBL] [Abstract][Full Text] [Related]
11. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
12. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
[TBL] [Abstract][Full Text] [Related]
13. [CNS metastases in malignant melanomas].
Willner J; Bohndorf W
Strahlenther Onkol; 1995 Mar; 171(3):165-73. PubMed ID: 7709333
[TBL] [Abstract][Full Text] [Related]
14. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy for metastatic brain tumors from lung cancer--a review to devise individualized treatment plans.
Itoh Y; Fuwa N; Morita K
Nagoya J Med Sci; 2003 Nov; 66(3-4):119-28. PubMed ID: 14727688
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
17. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
19. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
Mehta MP; Rodrigus P; Terhaard CH; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R; Schultz C; Timmerman R; Curran W; Smith J; Phan SC; Miller RA; Renschler MF
J Clin Oncol; 2003 Jul; 21(13):2529-36. PubMed ID: 12829672
[TBL] [Abstract][Full Text] [Related]
20. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
